Genomic Instability and Mutations at CIOC 2027

Genomic instability and mutations are central to cancer development and progression, as they contribute to the transformation of normal cells into malignant ones. Genomic instability refers to the increased rate of mutations within the DNA of a cell, leading to abnormal growth patterns. This instability can arise from various factors, including exposure to carcinogens, inherited genetic defects, or errors during cell division. Mutations in key genes, such as tumor suppressors and oncogenes, can drive the uncontrolled proliferation of cancer cells. Understanding the molecular mechanisms behind genomic instability is crucial for developing targeted therapies that address the root causes of cancer. Advances in genomic sequencing have enabled researchers to identify specific mutations that may be driving individual cancers, allowing for more personalized and effective treatments. By targeting these mutations, therapies can be designed to selectively kill cancer cells while sparing healthy tissue, improving both the efficacy and safety of treatment options.